HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹158 Cr | ₹202 Cr | ₹254 Cr | ₹233 Cr | ₹198 Cr |
What is the latest Total Non-Current Liabilities ratio of HESTER BIOSCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹158 Cr |
| Mar2025 | ₹202 Cr |
| Mar2024 | ₹254 Cr |
| Mar2023 | ₹233 Cr |
| Mar2022 | ₹198 Cr |
How is Total Non-Current Liabilities of HESTER BIOSCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹158 Cr | -21.77 | |
| Mar2025 | ₹202 Cr | -20.65 | |
| Mar2024 | ₹254 Cr | 9.14 | |
| Mar2023 | ₹233 Cr | 17.61 | |
| Mar2022 | ₹198 Cr | - | |
Compare Total Non-Current Liabilities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,780.1 Cr | -5.2% | 7.1% | 15.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -5.2% |
7.1% |
15.8% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses